ArloJMillerMDPhD

PubMed

• 11 citations
  Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor phosphorylation through the S1P3 receptor subtype.
  Dong-Seok Kim, Seo-Hyoung Park, Yun-Mi Jeong, Sun-Bang Kwon, Arlo J. Miller, David E. Fisher, Kyoung-Chan Park> ;The Journal of Pharmacy and Pharmacology. 2011 Mar 1
• The pathway ahead in melanoma trials.
  Arlo J. Miller, Svetomir N. Markovic, Paul Haluska> ;Oncology. 2009 May 1
• 89 citations
  Malignant melanoma in the 21st century: the emerging molecular landscape.
  Aleksandar Sekulic, Paul Haluska, Arlo J. Miller, Josep Genebriera De Lamo, Samuel Ejadi, Jose S. Pulido, Diva R. Salomao, Erik C. Thorland, Richard G. Vile, David L. ...> ;Mayo Clinic Proceedings. 2008 Jul 1
• 20 citations
  The molecular basis of melanomagenesis and the metastatic phenotype.
  A. Neil Crowson, Cynthia M. Magro, Arlo J. Miller, Martin C. Mihm> ;Seminars in Oncology. 2007 Dec 1
• 74 citations
  Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders
  Kayo Sato-Jin, Emi K. Nishimura, Eijiro Akasaka, Wade E. Huber, Hajime Nakano, Arlo J. Miller, Jinyan Du, Min Wu, Katsumi Hanada, Daisuke Sawamura, David E. Fisher, Ge...> ;FASEB Journal. 2008 Apr 1
• Melanoma.
  Miller, A.J., Mihm, M.C.> ;N Engl J Med. 2006 Jul 6
• 114 citations
  Sumoylation of MITF and its related family members TFE3 and TFEB.
  Arlo J. Miller, Carmit Levy, Ian J. Davis, Ehud Razin, David E. Fisher> ;The Journal of Biological Chemistry. 2005 Jan 7
• 159 citations
  Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.
  Arlo J. Miller, Jinyan Du, Sheldon Rowan, Christine L. Hershey, Hans R. Widlund, David E. Fisher> ;Cancer Research. 2004 Jan 15
• 220 citations
  MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin A. Horstmann, Sridhar Ramaswamy, David E. Fisher> ;The American Journal of Pathology. 2003 Jul 1
• Join now to see all

Journal Articles

• The Molecular Basis of Melanomagenesis and the Metastatic Phenotype.  
  Crowson AN, Magro C, Miller A, Mihm MC Jr, Seminars in Oncology
• Epistatic Connections between MITF and Endothelin Signaling in Waardenburg Syndrome and Other Pigmentary Disorders.  
  Sato-Jin K, Nishimura EK, Akasaka E, Huber W, Nakano H, Miller A, Du J, Wu M, Hanada K, Sawamura D, Fisher DE, and Imokawa G, EMBO
• New insights into pigmentary pathways and skin cancer.  
  Miller AJ, Tsao H, British Journal of Dermatology
• Malignant Melanoma in the 21st Century, Part 3: The Emerging Molecular Landscape.  
  Sekulic A, Haluska P Jr, Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic..., Mayo Clinic Proceedings. 2008 Jul;83(7):825-46
• Join now to see all

Abstracts/Posters

• High definition clonal analysis of human melanoma.
  A Sekulic, A Miller, M Barrett, A Mengos, M Pittelkow, Society of Investigative Dermatology, Montreal
• Identification of targetable cellular subsets within melanoma tumors.
  A. Sekulic, A. Miller, M. Barrett, S. Ejadi, A. Mengos, B. Pockaj, S. Markovic, American Society of Clinical Oncology, Orlando
• Personalized approach to analysis of melanoma tumor heterogeneity with potential implications for therapy.
  A. Miller, M. Barrett, A. Mengos, M. Pittelkow, A. Sekulic, American Academy of Dermatology, Boston